Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis
Open Access
- 1 December 2000
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 84 (12) , 1423-1425
- https://doi.org/10.1136/bjo.84.12.1423
Abstract
AIMS To determine whether macrophage migration inhibitory factor (MIF) levels were increased in sera of the patients with iridocyclitis. METHODS Sera were obtained from 41 patients with acute iridocyclitis, 13 patients with chronic iridocyclitis, and 44 healthy control subjects. MIF levels were determined by a human MIF ELISA. RESULTS The average levels of MIF in the sera of patients with both acute and chronic iridocyclitis were significantly higher than that of healthy subjects. CONCLUSION Uveitis induces the elevation of serum MIF, which may affect various inflammatory symptoms in uveitis.Keywords
This publication has 16 references indexed in Scilit:
- Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodiesCurrent Eye Research, 2000
- Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.Proceedings of the National Academy of Sciences, 1996
- MIF as a glucocorticoid-induced modulator of cytokine productionNature, 1995
- The role of cytokines in ocular inflammation.British Journal of Ophthalmology, 1994
- MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemiaNature, 1993
- Cytokines and uveitis, a reviewCurrent Eye Research, 1992
- Uveitis and systemic disease.British Journal of Ophthalmology, 1992
- Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.British Journal of Ophthalmology, 1984
- Mechanism of a Reaction in Vitro Associated with Delayed-Type HypersensitivityScience, 1966